CClinicalTrials.gg
Status unknownNCT03275441SHERGUpdated Sep 7, 2017

Electroretinography: Investigation of a Protocol Change

An observational study in Dark-adapted ERG, sponsored by NHS Greater Glasgow and Clyde. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-09-07.

Sponsored by NHS Greater Glasgow and Clyde · Observational

The sponsor has not verified this record recently (last verified Sep 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
262
Ages
18 Years and older
Sex
All
01

Study summary

The study evaluates whether an eye test called an electroretinogram (ERG) can be shortened and still produce the same diagnostic results. The results of this study may allow test times to be reduced which will have benefits such as improved patient compliance during shorter testing and increased clinic efficiency.

Read the detailed description

A full-field electroretinogram (ERG) is a standardised eye test undertaken in specialist hospital clinics. ERGs are useful for diagnosing and monitoring retinal diseases. The retina is stimulated by showing patients flashes of light and the resulting electrical response from the eye is recorded using delicate electrodes that touch the surface of the eye. For the first section of the test, patient's eyes are allowed to adjust to the dark to ensure the parts of the retina responsible for seeing in dimly-lit conditions are being tested.

The international ERG Standard says patients must sit in the dark for 20 minutes. The investigators have evidence to suggest the test may be equally useful after only 10 minutes in the dark. The investigators plan to compare ERGs recorded from patients who have spent only 10 minutes in the dark with ERGs recorded from the same patients after the full 20 minutes in the dark. If the difference is suitably small, as found in a preliminary study of healthy individuals, it could be justifiable to shorten the routine patient protocol.

Subjects for this study will be recruited from the adult population routinely attending for an outpatient ERG test. During their routine ERG test, 10 minutes into the 20 minute wait in the dark, the investigators propose recording an additional, identical set of ERG tests. This will not add extra time to the clinical test.

Participants will not need any follow-up for the research study. The study requires 262 patients to test the hypothesis, and the investigators estimate this will take about 5-6 months.

02

Conditions studied

  • Dark-adapted ERG

Keywords

  • electroretinogram
  • ERG
  • dark-adaptation
  • ophthalmology
  • electrophysiology
  • ISCEV
  • electroretinography
  • scotopic
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patient population attending hospital for routine clinical electroretinography.

Inclusion criteria

  • Patients referred to the adult visual electrophysiology service regardless of clinical condition, and who require dark-adapted electroretinography as part of their appointment
  • Male or female
  • All ethnicities

Exclusion criteria

Exclusion Criteria:

  • Patients less than 18 years old
  • Patients who might have difficulties understanding the participant information provided (for example, those patients requiring a translator, or who have learning difficulties)
  • Patients with photosensitive epilepsy
  • Patients appointed for clinical testing urgently, or via telephone, who will not have had an opportunity to receive and review the participant information sheet ahead of the clinical appointment.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
262 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adult patients

    Adult patients attending hospital for clinical visual electrophysiology.

    Diagnostic Test: Electroretinography

Interventions

  • Diagnostic testElectroretinography

    An additional electroretinogram performed after 10 minutes of dark adaptation.

05

What researchers measure

Primary outcomes

  1. Rate of classification for ERG following 10 minute dark adaptation

    The rate of classification (normal vs abnormal) for testing conducted after 10 minutes of dark adaptation.

    Time frame: (During first & only study visit) Dark-adapted ERG test following 10 minutes of dark adaptation

  2. Rate of classification (normal vs abnormal) for ERG following 20 minute dark adaptation

    The rate of classification (normal vs abnormal) for testing conducted after 20 minutes of dark adaptation.

    Time frame: (During first & only study visit) Dark-adapted ERG test following 20 minutes of dark adaptation

Secondary outcomes

  1. Response amplitude after 10 minutes

    Measurement of the amplitude of responses following 10 minutes of dark adaptation.

    Time frame: (During first & only study visit) Dark-adapted ERG test following 10 minutes of dark adaptation

  2. Response amplitude after 20 minutes

    Measurement of the amplitude of responses following 20 minutes of dark adaptation.

    Time frame: (During first & only study visit) Dark-adapted ERG test following 20 minutes of dark adaptation

  3. Response timing

    Measurement of the amplitude of responses following 10 minutes of dark adaptation.

    Time frame: (During first & only study visit) Dark-adapted ERG test following 10 minutes of dark adaptation

  4. Response timing

    Measurement of the amplitude of responses following 20 minutes of dark adaptation.

    Time frame: (During first & only study visit) Dark-adapted ERG test following 20 minutes of dark adaptation

  5. Response variability

    Measurement of the variability of responses following 10 minutes of dark

    Time frame: (During first & only study visit) Dark-adapted ERG test following 10 minutes of dark adaptation

  6. Response variability

    Measurement of the variability of responses following 20 minutes of dark

    Time frame: (During first & only study visit) Dark-adapted ERG test following 20 minutes of dark adaptation

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03275441
Lead sponsor
NHS Greater Glasgow and Clyde
Responsible party
Sponsor
First posted
Sep 7, 2017
Start date
Oct 2017 (estimated)
Primary completion
Feb 2018 (estimated)
Completion
Feb 2018 (estimated)
Last update
Sep 7, 2017

Study contacts

Ruth Hamilton, PhD
Contact
ruth.hamilton@glasgow.ac.uk
01414524217
Kirsten Graham, MSc
Contact
kirsten.graham@nhs.net
01412112758
Ruth Hamilton, PhD
study director · NHS Greater Glasgow & Clyde
Kirsten Graham, MSc
principal investigator · NHS Greater Glasgow & Clyde
Richard Hagan, PhD
principal investigator · NHS Royal Liverpool University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion